Mark Slifka, Ph.D., pioneers new approach in vaccine development
Researchers at the Oregon National Primate Research Center have created a new vaccine development technique using a solution previously thought too damaging to be useful in vaccine production. Mark Slifka, Ph.D., and colleagues have successfully utilized hydrogen peroxide as a virus inactivator in the generation of three distinct vaccines. Vaccines for West Nile, Lymphocytic choriomeningitis, and vaccinia viruses have been created using this new technique, which supports the researchers’ claims that this could truly be a new platform technology in vaccine development.
Najít Technologies, an Oregon-based biotech company founded by Slifka and colleagues, has been working together with OHSU in the development of these vaccines and is confident that their findings, published online in the journal Nature Medicine, will help them to expand the commercial vaccine industry here in Portland.
Read the full article.
Recent Comments
- Quen on Phillip Marucha, D.M.D., Ph.D., is new School of Dentistry dean
- Sandy Pierce on Doernbecher researchers first to grow transplantable liver stem cells in culture
- Susan Oliver on 125th lecture series: Eric Dishman on accelerating personal health, April 1
More Comments